Yale University Cancer Center

New Haven, Connecticut 06520-8028

7 studies enrolling now · 17 studies all time

What they study most

Advanced Solid Tumor, Advanced Solid Tumors, Advanced or Metastatic Solid Tumors, Anal Squamous Cell Carcinoma, Bladder Cancer, Breast Cancer, CRC, Cancer, Cancer Central Nervous System, Cancer Gynecologic, Cancer Head and Neck, Cancer Thoracic

Studies at this site

• A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas — Recruiting now
• A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations — Recruiting now
• A Study of ASP1002 in Adults for Treatment of Solid Tumors — Recruiting now
• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) — Recruiting now
• ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours — Recruiting now
• TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd — Recruiting now
• Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System — Recruiting now
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors — Running, not enrolling
• GEN1046 Safety Trial in Patients With Malignant Solid Tumors — Running, not enrolling
• Niraparib + Dostarlimab In BRCA Mutated Breast Cancer — Running, not enrolling
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
• Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) — Completed
• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma — Completed
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors — Completed
• Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Head and Neck Cancer — Stopped early
• Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) — Status unconfirmed